Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.73 |
| ▸ | NPC1 | O15118 | 1/20 | 0.58 |
| ▸ | HTR4 | Q13639 | 7/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.55 |
| ▸ | HTR3A | P46098 | 2/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.53 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.53 |
| ▸ | HTR3B | O95264 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | MPO | P05164 | 1/20 | 0.53 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.53 |
| ▸ | DRD2 | P14416 | 1/20 | 0.53 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.53 |
| ▸ | DRD4 | P21917 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7442414 | 0.98 | GAA (0.71) | GAANPC1HTR4CYP1A2CYP2D6 | |
| SCHEMBL7412182 | 0.86 | GAA (0.55) | GAANPC1HTR4CYP1A2CYP2D6 | |
| SCHEMBL856225 | 0.86 | GAA (0.58) | GAANPC1HTR4CYP1A2CYP2D6 | |
| SCHEMBL725809 | 0.86 | GAA (0.73) | GAANPC1HTR4CYP1A2CYP2D6 | |
| SCHEMBL7351910 | 0.86 | GAA (0.73) | GAANPC1HTR4CYP1A2CYP2D6 | |
| SCHEMBL7280230 | 0.86 | GAA (0.73) | GAANPC1HTR4CYP1A2CYP2D6 | |
| SCHEMBL29918211 | 0.86 | GAA (0.58) | GAANPC1HTR4CYP1A2CYP2D6 | |
| SCHEMBL1965781 | 0.85 | ALDH1A1 (0.61) | GAACYP3A4ALDH1A1LMNAGLA | |
| SCHEMBL31634578 | 0.85 | ALDH1A1 (0.61) | GAACYP3A4ALDH1A1LMNAGLA | |
| SCHEMBL3387534 | 0.85 | ALDH1A1 (0.56) | GAANPC1ALDH1A1KCNH2RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1069 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119977828-A | Methoxychlor-pup Process for the preparation of amines | 河南优凯制药有限公司 | 2025-05-13 | — | — | CN | claimed |
| CN-119977827-A | Methoxychlor-pram intermediate and preparation method and application thereof | 河南优凯制药有限公司 | 2025-05-13 | — | — | CN | claimed |
| EP-1799791-B1 | PHOTOCROSSLINKABLE MATERIALS | ROLIC AG (CH) | 2016-01-13 | — | — | EP | claimed |
| EP-1919909-B1 | SYNTHETIC METHODS AND INTERMEDIATES FOR STEREOISOMERIC COMPOUNDS USEFUL FOR THE TREATMENT OF GASTROINTESTINAL AND CENTRAL NERVOUS SYSTEM DISORDERS | ARMETHEON INC (US) | 2013-08-21 | — | — | EP | claimed |
| EP-1668082-B1 | LAKED AZO RED PIGMENT AND PROCESSES FOR PREPARATION AND USE | BASF CATALYSTS LLC (US) | 2013-01-09 | — | — | EP | claimed |
| CN-102863374-A | Synthetic methods and intermediates for stereoisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders | ARYX THERAPEUTICS | 2013-01-09 | — | — | CN | claimed |
| CN-101258151-B | Process for the synthesis of stereoisomeric compounds useful in the treatment of gastrointestinal and central nervous system disorders and intermediates | ARYX THERAPEUTICS INC | 2012-10-10 | — | — | CN | claimed |
| CN-101040028-B | Photocrosslinkable materials | ROLIC AG | 2012-03-28 | — | — | CN | claimed |
| US-7687118-B2 | Photocrosslinkable materials | ROLIC AG (CH) | 2010-03-30 | — | — | US | claimed |
| EP-1503764-B1 | 5-HT4 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF HEART FAILURE | SERODUS AS (NO) | 2010-01-06 | — | — | EP | claimed |
| WO-1998016511-A1 | SYNTHESIS OF CISAPRIDE | JANSSEN PHARMACEUTICA N.V. (BE) | 1998-04-23 | — | — | WO | claimed |
| US-5717098-A | GAMMA-LACTONE CHEMICAL INTERMEDIATE, USED TO PRODUCE A SINGLE ENANTIOMER OF AMINOAZANORADAMANTANE WHICH IS COUPLED TO AROMATIC ACID DERIVEATIVE TO PRODUCE A COMPOUND USEFUL AS 5-HT-AGONISTS OR ANTAGONSITS | G. D. SEARLE & CO. (US) | 1998-02-10 | — | — | US | claimed |
| WO-1996000729-A2 | PROCESS FOR THE PREPARATION OF AZANORADAMANTANE BENZAMIDES | G.D. SEARLE & CO. (US) | 1996-01-11 | — | — | WO | claimed |
| WO-1995025100-A1 | USE OF 4-AMINO-5-CHLORO-2-METHOXYBENZOIC ESTERS AS 5-HT4 AGONISTS | SANOFI (FR) | 1995-09-21 | — | — | WO | claimed |
| WO-1995021168-A1 | MESO-AZANORADAMANTANES | G.D. SEARLE & CO. (US) | 1995-08-10 | — | — | WO | claimed |
| EP-0190915-B1 | Process for the preparation of 2-alkoxy-N-(1-azabicyclo[2.2.2]octan-3-yl) aminobenzamides | SYNTHELABO (FR) | 1992-10-28 | — | — | EP | claimed |
| US-4950766-A | Preparation of benzamides useful as antiemetic agents | ERBAMONT, INC. (US) | 1990-08-21 | — | — | US | claimed |
| US-4870181-A | AMIDATION OF 3-AMINOQUINUCLIDINE SALT | A. H. ROBINS COMPANY, INCORPORATED (US) | 1989-09-26 | — | — | US | claimed |
| EP-0314483-A1 | Preparation of benzamides | ERBAMONT, INC. (US) | 1989-05-03 | — | — | EP | claimed |
| EP-0190915-A2 | Process for the preparation of 2-alkoxy-N-(1-azabicyclo[2.2.2]octan-3-yl) aminobenzamides | SYNTHELABO (FR) | 1986-08-13 | — | — | EP | claimed |